Delivery Order SPE2DR25D3103-SPE2DR26F9M05
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $3,954.76. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Adderall XR 25 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,316.56. This non-set-aside delivery order, which must be completed by November 17, 2025, represents a pharmaceutical supply requirement with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $3,492.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,457.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (quantity: 100 count) on December 4, 2025, with a ceiling value of $2,321.68 and an ultimate completion date of December 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,592.16. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,919.78 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) on November 17, 2025, with a completion date of November 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under a larger vehicle. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, which serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.09 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (quantity: 100s) on November 7, 2025, with an ultimate completion date of November 10, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,594.81 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on December 4, 2025, with completion expected by December 5, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,094.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price contract utilizes no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9M05Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall XR 20 mg capsules (100 count) with a ceiling value of $18,892.20. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, represents a competitively awarded, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contracting presence with DLA and serves as a critical supplier for military and veteran healthcare systems. The company's extensive contract portfolio encompasses a wide range of pharmaceutical products, medical supplies, and specialty medications across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for controlled pharmaceutical inventory reflects the company's ongoing role as a key vendor within the federal medical supply chain, specifically supporting DLA's pharmaceutical distribution operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 12/3/25 |